ALRM
Alarm.com Holdings, Inc.
ALRM has the edge over ASTS overall, supported by lower modeled downside and stronger valuation.
ASTS
AST SpaceMobile, Inc.
ASTS offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
ALRM Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Strong | |
| Healthy |
ALRM's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
ALRM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 22x | $66.42 | — |
| Cheap | 24x | $53.89 | -19% |
| Current | 29x | $66.42 | — |
| Fair | 45x | $103 | +55% |
| Expensive | 62x | $140 | +112% |
Historical ranges are pointers, not guarantees.
ALRM's PE is in its cheap range at 29x. If earnings grow as analysts expect, today's price would be 22x next year's earnings.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
ALRM Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for ALRM, with profitability holding steady.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
ALRM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.99 | +32% |
| Q3 2026 | $2.27 | -3.8% |
| Q2 2026 | $2.26 | -5% |
| Q1 2026 | $2.41 | +1.7% |
| Q4 2025 | $2.46 | +7.4% |
| Q3 2025 | $2.36 | +2.2% |
| Q2 2025 | $2.38 | +18% |
| Q1 2025 | $2.37 | +40% |
| Q4 2024 | $2.29 | +50% |
ALRM has the edge over ASTS on earnings quality, reporting a profit while its opponent remains loss making.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
ASTS is still losing money, but far less than before: $2.15 per share over the past year, against $5.76 at its worst in mid-2021.
ALRM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $279.4M | +9% |
| Q2 2026 | $277.7M | +9.2% |
| Q1 2026 | $265.2M | +11% |
| Q4 2025 | $261.7M | +8% |
| Q3 2025 | $256.4M | +6.6% |
| Q2 2025 | $254.3M | +8.8% |
| Q1 2025 | $238.8M | +7% |
| Q4 2024 | $242.2M | +7.1% |
ALRM's revenue has grown year over year every quarter since late 2020: $279M last quarter, up 9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 16% | +1.3 points |
| Q2 2026 | 12% | -0.9 points |
| Q1 2026 | 12% | -0.5 points |
| Q4 2025 | 13% | +0.6 points |
| Q3 2025 | 14% | +0.6 points |
| Q2 2025 | 13% | +1.6 points |
| Q1 2025 | 12% | +4 points |
| Q4 2024 | 13% | +1.4 points |
ALRM has the edge over ASTS on profitability, with a higher operating margin.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS's revenue has grown year over year for 11 quarters in a row: $42M last quarter, up 187% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS's operating margin was −415% last quarter, up 694 points from the same quarter a year ago.
ALRM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $69.5M | +5.5% |
| Q2 2026 | $37M | +104% |
| Q1 2026 | $49.7M | +177% |
| Q4 2025 | $35.1M | -35% |
| Q3 2025 | $65.9M | -12% |
| Q2 2025 | $18.2M | -13% |
| Q1 2025 | $17.9M | -62% |
| Q4 2024 | $54M | +43% |
ALRM has the edge over ASTS on cash generation, producing positive trailing cash flow while its opponent burns cash.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
ASTS has burned cash in almost every quarter: −$1.8B over the past year, against −$916M the year before.
ALRM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +58K shares |
| 1 year | -4.2% | -2.5M shares |
| 3 years | +2.2% | +1.2M shares |
| 5 years | +8% | +4.1M shares |
| Available history | +11% | +5.7M shares |
ALRM has the edge over ASTS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $13.4M |
| Q2 2026 | $25M |
| Q1 2026 | $20M |
| Q4 2025 | $19.1M |
| Q3 2025 | $12.3M |
| Q2 2025 | $5.1M |
| Q1 2025 | $5.1M |
| Q4 2024 | — |
ALRM spent $78M buying back its own shares over the past year, about three times what it spent the year before.
ASTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +1.1M shares |
| 1 year | +10% | +27.3M shares |
| 3 years | +235% | +211M shares |
| 5 years | +480% | +248M shares |
| Available history | +944% | +271M shares |
ASTS has 300M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
ALRM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -3.0x | Net Cash |
| Q2 2026 | -2.8x | Net Cash |
| Q1 2026 | -3.0x | Net Cash |
| Q4 2025 | -5.8x | Net Cash |
| Q3 2025 | -6.7x | Net Cash |
| Q2 2025 | -6.6x | Net Cash |
| Q1 2025 | -8.0x | Net Cash |
| Q4 2024 | -8.9x | Net Cash |
ALRM has more cash than debt.
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ALRM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 74.2 | Overbought |
| Stochastic | 80.3 | Overbought |
ALRM's weekly RSI is 74 (overbought) and its Stochastic is 80 (overbought).
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
ALRM PE vs Technology Sector
| Metric | ALRM | Sector median | Relative |
|---|---|---|---|
| PE | 29x | 28x | 5% above |
| PE % | 31 | 35 | 4 pts below |
ALRM is trading at 29x earnings, in line with the Technology sector's median of 28x.
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
ALRM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $60.2 | 10% above |
| 20 week MA | $56.8 | 17% above |
| 50 week MA | $51.1 | 30% above |
| 100 week MA | $53.5 | 24% above |
| 200 week MA | $56.2 | 18% above |
ALRM has the edge over ASTS on trend strength, trading above more of its moving averages.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has fallen below most of its moving averages, though it's still 2.8% above its 200-week average.
ALRM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $42.8 | $98.9 | +131% |
| 2021 | $98.9 | $82.8 | -16% |
| 2022 | $82.8 | $49.0 | -41% |
| 2023 | $49.0 | $64.6 | +32% |
| 2024 | $64.6 | $62.1 | -3.9% |
| 2025 | $62.1 | $51.8 | -17% |
| 2026 YTD | $51.8 | $66.4 | +28% |
ALRM has the edge over ASTS on returns for 2026, with the stronger performance.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS's yearly returns have swung widely, from +280% in 2024 to −54% in 2022. It's down 52% so far in 2026.